Helen X. Chen, MD | Authors

46 W. Parish Dr.

Andover

01810-3350

Articles

Current Clinical Trials of the Anti-VEGF Monoclonal Antibody Bevacizumab

August 01, 2001

Given the well-established role of angiogenesis (or new blood vessel formation) in tumor growth and metastasis, antiangiogenic therapy, a concept first proposed by Dr. Judah Folkman,[1] has become increasingly recognized as a promising